Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.23M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -14M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.39
x | P/E ratio 2025 * |
-0.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.74% |
Latest transcript on Processa Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 11-03-28 |
Sian Bigora
FOU | Founder | 63 | 11-03-28 |
David Young
FOU | Founder | 71 | 11-03-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 23-08-07 |
James Neal
BRD | Director/Board Member | 68 | 22-07-15 |
Justin Yorke
CHM | Chairman | 58 | 17-10-01 |
1st Jan change | Capi. | |
---|---|---|
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |